Cost

Mounjaro Coupon Guide: Who Qualifies and How to Apply

GLP-1 Companion · 8 min read

Mounjaro coupon searches are often messy because the same molecule sits behind two different commercial paths: Mounjaro for type 2 diabetes and Zepbound for weight management. The coupon question is really an indication question first.

My position: do not chase a Mounjaro discount if the labeled path does not match your diagnosis. Ask which prescription path fits your medical situation, then compare insurance, savings-card, and partner-provider options. If you still need a clinician, start with /partners.

The Lilly Mounjaro Savings Card

Eli Lilly's Mounjaro Savings Card is the primary tool for reducing out-of-pocket costs for commercially insured patients. Under this program, eligible patients may pay approximately $25–35 per month for Mounjaro, with Lilly covering the difference between that amount and the amount charged after insurance.

The exact per-month amount has varied since Mounjaro's 2022 launch, and the specific terms should always be verified at mounjaro.com before relying on them for financial planning. Historically, Lilly has maintained the Mounjaro card at or near the $25/month level for patients with commercial insurance that covers the medication.

The Type 2 Diabetes Diagnosis Requirement

Mounjaro is approved only for Type 2 diabetes — not for obesity, weight management, or any other indication. This approval distinction has significant implications for savings program eligibility and insurance coverage.

To use the Mounjaro Savings Card, you must have a valid prescription for Mounjaro for Type 2 diabetes. Prescribers cannot prescribe Mounjaro off-label for obesity and expect the savings card to apply — the claim filed with insurance will reflect the diabetes indication, and savings programs are tied to approved indications.

• If you have Type 2 diabetes and obesity, Mounjaro may be the appropriate prescription — it treats your primary diagnosis and produces substantial weight loss as a secondary benefit.
• If you have obesity without Type 2 diabetes, Zepbound (same molecule, obesity indication) is the appropriate prescription and has its own savings program.
• Some patients with prediabetes and obesity have received Mounjaro prescriptions for diabetes prevention, but this is off-label and insurance and savings program eligibility becomes complex.
• The A1c and fasting glucose thresholds that define Type 2 diabetes (A1c ≥ 6.5% or fasting glucose ≥ 126 mg/dL on two separate occasions) are the relevant clinical criteria.

Eligibility Requirements

The Mounjaro Savings Card has the standard commercial insurance eligibility requirements plus the diagnosis requirement.

• Must have commercial health insurance (employer plans, marketplace plans, COBRA). Medicare and Medicaid are excluded.
• Must have a valid Type 2 diabetes diagnosis and Mounjaro prescription for that indication.
• Must be a US resident.
• Government insurance programs (TRICARE, VA, Indian Health Service) are excluded.
• Annual income is not a factor for the commercial savings card — unlike the Lilly Cares patient assistance program.
• The program requires an insurance claim to be filed; uninsured patients must use the Lilly Cares Foundation (see below).

Not Valid with Medicare or Medicaid

As with all manufacturer savings programs, the Mounjaro Savings Card is prohibited from use with Medicare Part D, Medicare Advantage (which includes prescription drug benefits), Medicaid, and dual-eligible plans. This exclusion is a federal legal requirement under the anti-kickback statute — manufacturers cannot subsidize cost-sharing for federal healthcare programs.

For Medicare patients, Mounjaro coverage depends on whether the specific Medicare Part D plan covers tirzepatide for Type 2 diabetes. Many Part D plans do cover Mounjaro as a non-insulin diabetes medication, and cost-sharing through Medicare depends on the plan tier. Low Income Subsidy (LIS/Extra Help) recipients may pay $1.50–$10 per month. For others, monthly costs typically fall in the $45–$200 range depending on plan and coverage phase.

How to Apply for the Mounjaro Savings Card

The enrollment process for the Mounjaro Savings Card is designed to be completed before or at the time of your first fill.

1. Visit mounjaro.com and navigate to the savings or cost support section.
2. Click to enroll and complete the form with your name, date of birth, address, and commercial insurance details.
3. Confirm eligibility — the site will flag Medicare/Medicaid disqualification in real time.
4. Receive your savings card information (BIN, PCN, Group ID, and Member ID) digitally or by mail.
5. Provide the card information to your pharmacy (retail or specialty) when filling the prescription.
6. Alternatively, your prescriber's office may pre-enroll you at the time of prescribing — ask if they have Lilly savings card enrollment resources on hand.
7. For subsequent fills, the card information remains the same through the program year. Renew enrollment annually.

Lilly Cares Foundation: For Uninsured Patients

The Lilly Cares Foundation is Eli Lilly's patient assistance program providing free medications to uninsured patients who meet income eligibility criteria. For Mounjaro, the program covers patients who lack commercial insurance and meet the income threshold.

• Income eligibility: At or below 400% of the federal poverty level (approximately $60,240 for a single adult in 2026).
• Insurance status: Must be uninsured or have insurance that explicitly excludes coverage for Mounjaro.
• Application: lillycares.com or 1-800-545-5979. Your prescriber must complete an enrollment section.
• Required documentation: Recent tax return or pay stubs, proof of insurance status (or lack thereof), and prescriber information.
• Processing: Typically 2–4 weeks. Your prescriber's office can expedite by completing their section promptly.
• Approval provides free medication shipped directly to the patient or to the prescriber's office.
• Annual renewal with updated income documentation.

GoodRx for Mounjaro

GoodRx prices for Mounjaro in early 2026 typically range from $850 to $1,000 per month, varying by pharmacy location and specific dose. This is meaningfully below Mounjaro's list price and may be comparable to or better than insurance cost-sharing for patients with high deductibles or poor formulary placement.

Mounjaro through GoodRx is accessible at more retail pharmacies than Wegovy or Zepbound, which require specialty pharmacy dispensing. This makes GoodRx a more practical secondary tool for Mounjaro than for the obesity-indication GLP-1s. Note that GoodRx and the Lilly Savings Card cannot be used simultaneously — GoodRx replaces insurance, while the savings card requires an insurance claim.

Transition to Zepbound: When It Makes Sense

A notable consideration for patients on Mounjaro who have obesity (with or without Type 2 diabetes) is whether transitioning their prescription to Zepbound — the same molecule with an obesity indication — might improve coverage or savings.

• If your employer insurance covers Zepbound for obesity but not Mounjaro for T2D (or vice versa), your prescriber can write the prescription for the covered indication.
• For patients who have achieved glycemic control and whose primary continued concern is weight management, a Zepbound prescription may better reflect clinical reality.
• Some patients with both T2D and obesity find that Mounjaro's T2D formulary coverage is more robust than Zepbound's obesity formulary coverage under their specific plan — in which case staying on Mounjaro is the cost-optimal choice.
• The transition from Mounjaro to Zepbound (or vice versa) requires a new prescription from your prescriber. The doses are equivalent, so no medical adjustment is needed — only an administrative prescription change.

Realistic Cost Scenarios for Mounjaro in 2026

• Commercially insured (T2D, Mounjaro covered), savings card: $25–35/month.
• Commercially insured (T2D, Mounjaro NOT covered), GoodRx: $850–$1,000/month.
• Medicare Part D, Mounjaro on formulary (diabetes indication): $0–$200/month depending on plan and subsidy status.
• Medicare Part D, Mounjaro NOT on formulary: $850–$1,000/month out-of-pocket via GoodRx.
• Uninsured, meets Lilly Cares income criteria: $0/month.
• Uninsured, does not meet Lilly Cares criteria: $850–$1,000/month (GoodRx).

Key Takeaways

• The Lilly Mounjaro Savings Card can bring monthly costs to $25–35 for commercially insured Type 2 diabetes patients.
• A valid Type 2 diabetes diagnosis and prescription for that indication is required — the card is not available for off-label obesity prescriptions of Mounjaro.
• Medicare and Medicaid patients are excluded from the savings card; explore Medicare Part D formulary coverage instead.
• Uninsured patients meeting income criteria may receive free Mounjaro through Lilly Cares Foundation.
• GoodRx provides more meaningful savings for Mounjaro ($850–$1,000/month) than for obesity GLP-1s due to retail pharmacy availability.
• Patients with obesity who lack T2D should receive a Zepbound prescription rather than Mounjaro to access the appropriate savings program and insurance coverage.

The practical next step is to confirm diagnosis and coverage first, then compare provider paths through /partners if you need a licensed evaluation before any prescription is written.

Sources

• Jastreboff et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. NEJM.
• Mounjaro (tirzepatide) Prescribing Information. Eli Lilly.